Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 15.83 USD 0.06% Market Closed
Market Cap: 2B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neogenomics Inc
Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Revenue
$628.3m
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
24%
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.4B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
10%
Danaher Corp
NYSE:DHR
Revenue
$21.2B
CAGR 3-Years
-9%
CAGR 5-Years
6%
CAGR 10-Years
1%
Mettler-Toledo International Inc
NYSE:MTD
Revenue
$3.8B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Revenue
$6.5B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
13%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
11%

See Also

What is Neogenomics Inc's Revenue?
Revenue
628.3m USD

Based on the financial report for Jun 30, 2024, Neogenomics Inc's Revenue amounts to 628.3m USD.

What is Neogenomics Inc's Revenue growth rate?
Revenue CAGR 10Y
24%

Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Neogenomics Inc have been 9% over the past three years , 13% over the past five years , and 24% over the past ten years .

Back to Top